A study to assess the effect of verinurad on the electric activity of the heart

Trial Identifier:	D5495C00012
Sponsor:	AstraZeneca
Collaborator:	Parexel International
NCTID::	NCT04256629
Start Date:	March 2020
Primary Completion Date:	August 2020

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English version
	German Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Germany	Berlin, Germany, 14050

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.